National Network for Equitable Library Service

The fourth entry to John Straley's Alaska P.I. series finds Cecil Younger with a contract to kill.

Synthia Cross is the most advanced android with artificial intelligence ever created. Some see her as a boon to mankind. Most view her as a deadly threat.

The JT LeRoy scandal is a story of our times. In January 2006, the New York Times unmasked Savannah Knoop as the face of the mysterious author JT LeRoy.

During a rare white Christmas at Brambledean Court, the widow Elizabeth, Lady Overfield, defies convention by falling in love with a younger man in the latest novel in the Westcott series.

Most people are baffled by how computers work and assume that they will never understand them.

When an Old Order Amish woman takes a job at a small-town pharmacy struggling to survive in a world of "big box" stores, her motive is to help her Plain community.

In the sixth book featuring Donna Leon's ever-charming and sympathetic protagonist, Commissario Guido Brunetti comes to the aid of a young nursing sister who has had five patients unexpectedly die

Precious Ramotswe dips her toe into the world of politics in the newest addition to the beloved and best-selling No. 1 Ladies' Detective Agency series.

On their own, pranksters Miles and Niles were pretty devious. Now that they've formed a pranking duo, they're terrible!

A royal birth, a nobleman's death, and a scarlet woman's murder In March 1279 Edward I takes a break from hammering the Welsh and bearing down on England's Jews to vacation in Gloucestershire.

Are boys and girls really that different' Twenty years ago, doctors and researchers didn't think so.

The day Jingo rode into Tower Creek, the town was busy celebrating its twentieth anniversary.

From the Pulitzer Prize-winning, bestselling author of The Emperor of All Maladies-a magnificent history of the gene and a response to the defining question of the future: What becomes of being hum

In this candid and riveting memoir, for the first time ever, Nike founder and CEO Phil Knight shares the inside story of the company's early days as an intrepid start-up and its evolution into one

A "biography" of cancer from its origins to the epic battle to cure, control, and conquer it.